Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non‐small cell lung cancer: A case report

Cytokine release syndrome (CRS) is a severe and life‐threatening toxicity typically reported in chimeric antigen receptor T cell therapy and is rarely reported in immune checkpoint inhibitor (ICI) therapy. This study reports the case of a 75‐year‐old Japanese woman who received nivolumab plus ipilim...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsutsui, Toshiharu, Hata, Koki, Kawaguchi, Makoto, Kobayashi, Hiroaki, Kakizaki, Yumiko, Miyashita, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423655/
https://www.ncbi.nlm.nih.gov/pubmed/37381088
http://dx.doi.org/10.1111/1759-7714.15015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423655/
https://www.ncbi.nlm.nih.gov/pubmed/37381088
http://dx.doi.org/10.1111/1759-7714.15015

Ejemplares similares